Claims
- 1. A unit dosage pharmaceutical composition for the prevention of implanation of a blastocyst in the epithelial uterine lining of a female mammal and possessing a total per unit dosage of an accurate predetermined amount of an estrogen sulfotransferase inhibiting compound such that said dosage is administered daily for from 3 to 9 days in quantities each day of from 0.1 to 500 mg of the compound, wherein the compound is 4-fluoroestrone-3-methyl ether.
- 2. A method of treating a female mammal to prevent implanation of a blastocyst which method comprises administering an effective dosage of an estrogen sulfotransferase inhibiting compound wherein the compound is 4-fluoroestrone-3-methyl ether.
CROSS REFERENCE TO RELATED APPLICATION
This is a continuation of application Ser. No. 355,806 filed Mar. 8, 1982 now abandoned, which is a continuation-in-part of copending application Ser. No. 952,592, filed Oct. 18, 1978, now U.S. Pat. No. 4,340,602.
Government Interests
This invention described herein was made in the course of work under a Public Health Service Grant No. HD 14775-01 from the Department of Health, Education and Welfare.
Non-Patent Literature Citations (1)
Entry |
Utne et al., "Journal of Organic Chemistry", Jun. (1968), pp. 2469-2473. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
355806 |
Mar 1982 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
952592 |
Oct 1978 |
|